Open AccessOverexpression of AMPD2 indicates poor prognosis in colorectal cancer patients via the Notch3 signaling pathway
Author(s) -
Qiufeng Gao,
Qin Yan,
Weijia Wang,
Bojian Fei,
Wei Han,
Jin Jian,
Xiang Gao
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i15.3197
Subject(s) - colorectal cancer , tissue microarray , gene knockdown , cancer research , medicine , downregulation and upregulation , kegg , oncogene , immunohistochemistry , microarray analysis techniques , gene expression , cancer , biology , gene , cell cycle , transcriptome , genetics
AMPD2 is a critical enzyme catalyzing smooth muscle energy supply and metabolism; however, its cellular biological function and clinical implication in colorectal cancer (CRC) are largely unknown.